CellaVision AB (CLVSF)
14.00
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
CellaVision Research and Development Expense (Quarterly) : 3.179M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.179M |
| March 31, 2026 | 3.247M |
| December 31, 2025 | 2.333M |
| September 30, 2025 | 3.014M |
| June 30, 2025 | 2.315M |
| March 31, 2025 | 2.303M |
| December 31, 2024 | 1.883M |
| September 30, 2024 | 2.524M |
| June 30, 2024 | 1.869M |
| March 31, 2024 | 2.007M |
| December 31, 2023 | 1.798M |
| September 30, 2023 | 2.153M |
| June 30, 2023 | 1.967M |
| March 31, 2023 | 1.928M |
| December 31, 2022 | 1.796M |
| September 30, 2022 | 2.903M |
| June 30, 2022 | 2.082M |
| March 31, 2022 | 1.944M |
| December 31, 2021 | 1.866M |
| September 30, 2021 | 1.987M |
| June 30, 2021 | 1.800M |
| March 31, 2021 | 1.831M |
| December 31, 2020 | 1.813M |
| September 30, 2020 | 1.487M |
| June 30, 2020 | 1.337M |
| Date | Value |
|---|---|
| March 31, 2020 | 1.530M |
| December 31, 2019 | 1.623M |
| September 30, 2019 | 1.650M |
| June 30, 2019 | 1.463M |
| March 31, 2019 | 1.217M |
| December 31, 2018 | 1.325M |
| September 30, 2018 | 1.216M |
| June 30, 2018 | 1.016M |
| March 31, 2018 | 0.9332M |
| December 31, 2017 | 0.7228M |
| September 30, 2017 | 0.9081M |
| June 30, 2017 | 0.7235M |
| March 31, 2017 | 0.7866M |
| December 31, 2016 | 0.8374M |
| September 30, 2016 | 0.8693M |
| June 30, 2016 | 0.9297M |
| March 31, 2016 | 0.7814M |
| December 31, 2015 | 0.868M |
| September 30, 2015 | 0.6903M |
| June 30, 2015 | 0.9488M |
| March 31, 2015 | 0.708M |
| December 31, 2014 | 1.220M |
| September 30, 2014 | 0.7764M |
| June 30, 2014 | 0.6611M |
| March 31, 2014 | 0.6102M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| ALR Technologies SG Ltd. | -- |
| Carasent AB | -- |
| PHC Holdings Corp. | -- |
| SyntheticMR AB | -- |
| HealthStream, Inc. | 13.58M |